The Department of Cancer Immunology at the Institute for Cancer Research, Oslo University Hospital
The Olweus group (http://https://www.ous-research.no/olweus) offers a dynamic and stimulating scientific environment in a young, enthusiastic and motivated team of biologists and MDs. Projects in the group span from basic and translational immunology to development of a pipeline of cell therapies exploiting T cells genetically engineered to express therapeutic T-cell receptors. The first concepts have entered into clinical development, building on a long tradition of investigator-initiated trials at OUH.The group is also part of the Precision Immunotherapy Alliance, PRIMA, a Centre of Excellence hosted at the University of Oslo with Oslo University Hospital as partner.
The Institute for Cancer Research, Oslo University Hospital (OUH), Oslo, Norway (http://https://www.ous-research.no/institute/) hosts core facilities for multiparameter flow cytometry, next generation sequencing, imaging and bioinformatics, and also hosts a Department for Comparative Medicine. The Comprehensive Cancer Center (CCC) of OUH Radiumhospitalet is one of the largest Cancer Centers in Europe with its own Phase I/II clinical trial unit and a large academic facility for good manufacturing practices (GMP) production of cells for immunotherapy, housing a newly established Center for Advanced Cell and Gene Therapy (ACT). These units are integrated with the Department of Cancer Immunology (https://ous-research.no/immunology/) and clinical departments, giving OUH a competitive edge in bringing “in-house” discoveries to early clinical trials.
The project that the scientist will be working on involves immunopeptidomics to identify specific T-cell receptor targets for development of novel cancer immunotherapy, in collaboration with other members of the Olweus group.

 

Oslo University Hospital is a workplace with great diversity. We believe this is crucial to solving our tasks in the best possible way. We want this diversity to be reflected among the applicants for our positions, and encourage all qualified candidates, regardless of background, to apply.
 

Kvalifikasjoner:

The selected candidate must have:

• A degree equivalent to a Norwegian PhD degree in proteomics/ immunology/ biochemistry
• A thorough understanding and practical experience in mass spectrometry-based proteomics 
• Extensive experience with proteomics data analysis. 
• Extensive experience with immunopeptidomics workflow and data analysis.
• Experience with mammalian cell culture work.
• Authorship on strong publications involving immunopeptidomics data

The selected candidate should preferentially have

• At least 5 years postdoctoral experience with the above technologies/type of work
• Knowledge in human immunology and/or cellular signalling is an advantage. 

Personlige egenskaper:

• Strong motivation and interest in solving biological problems
• Diligence and commitment
• Ability to design, plan, execute and interpret experiments in an independent and innovative manner
• Excellent written and oral communication skills in English

Vi tilbyr:

Appointments will be for 3 years. Your application should include (in a single pdf):

• A one-page statement about your personal skills and qualifications.
• CV (summarizing education and positions)
• List of publications and academic work that the applicant wishes to be considered by the evaluation committee
• Names and contact details of three referees (name, relation to candidate, e-mail and telephone number)
  
  Candidates selected for interview might be asked to send transcripts and certificates at a later time.
  If you have questions, please contact Johanna Olweus M.D., Ph.D., Professor by e-mail for further information:  johanna.olweus@medisin.uio.no